Intracellular modulation of NMDA receptor function by antipsychotic drugs

Jean Christophe Leveque, Wendy Macías, Anjali Rajadhyaksha, Richard R. Carlson, Amy Barczak, Stanley Kang, Xin Min Li, Joseph T. Coyle, Richard L. Huganir, Stephan Heckers, Christine Konradi

Research output: Contribution to journalArticlepeer-review

Abstract

The present study deals with the functional interaction of antipsychotic drugs and NMDA receptors. We show that both the conventional antipsychotic drug haloperidol and the atypical antipsychotic drug clozapine mediate gene expression via intracellular regulation of NMDA receptors, albeit to different extents. Data obtained in primary striatal culture demonstrate that the intraneuronal signal transduction pathway activated by haloperidol, the cAMP pathway, leads to phosphorylation of the NR1 subtype of the NMDA receptor at 897Ser. Haloperidol treatment is likewise shown to increase 897Ser-NR1 phosphorylation in rats in vivo. Mutation of 896Ser and 897Ser to alanine, which prevents phosphorylation at both sites, inhibits cAMP-mediated gene expression. We conclude that antipsychotic drugs have the ability to modulate NMDA receptor function by an intraneuronal signal transduction mechanism. This facilitation of NMDA activity is necessary for antipsychotic drug-mediated gene expression and may contribute to the therapeutic benefits as well as side effects of antipsychotic drug treatment.

Original languageEnglish (US)
Pages (from-to)4011-4020
Number of pages10
JournalJournal of Neuroscience
Volume20
Issue number11
DOIs
StatePublished - Jun 1 2000

Keywords

  • CREB
  • Clozapine
  • D2 receptors
  • Haloperidol
  • NMDA
  • Proenkephalin
  • Striatum
  • Tardive dyskinesia
  • c- fos

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Intracellular modulation of NMDA receptor function by antipsychotic drugs'. Together they form a unique fingerprint.

Cite this